Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127744661 | 12774466 | 1 | I | 20160922 | 20160923 | 20160923 | PER | US-BAYER-2016-185060 | BAYER | 91.00 | YR | E | F | Y | 55.33000 | KG | 20160923 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127744661 | 12774466 | 1 | PS | CLARITIN REDITABS | LORATADINE | 1 | Oral | 1 DF, QD | L-NEF-18 | 21993 | 1 | DF | ORODISPERSIBLE TABLET | QD | |||||
127744661 | 12774466 | 2 | SS | CLARITIN REDITABS | LORATADINE | 1 | 21993 | ORODISPERSIBLE TABLET | |||||||||||
127744661 | 12774466 | 3 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
127744661 | 12774466 | 4 | C | BETAPACE | SOTALOL HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127744661 | 12774466 | 1 | Hypersensitivity |
127744661 | 12774466 | 2 | Nasopharyngitis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127744661 | 12774466 | Expired product administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |